EUVIMEDEUVIMED entdecken
Crossref

The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer

Masahiko Tanabe, Takayo Fukuda, Yoshinori Ito

Oncomedicine · 2017

DOI: 10.7150/oncm.21071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncomedicine, 2017. Verfasst von Masahiko Tanabe und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tanabe, M., Fukuda, T., & Ito, Y. (2017). The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer. Oncomedicine. https://doi.org/10.7150/oncm.21071

Vancouver

Tanabe M, Fukuda T, Ito Y. The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer. Oncomedicine. 2017. doi:10.7150/oncm.21071

BibTeX
@article{Tanabe2017,
  author = {Tanabe, Masahiko and Fukuda, Takayo and Ito, Yoshinori},
  title = {The Position of Combination Chemotherapy with Mitomycin C and Methotrexate in the Treatment of Metastatic Breast Cancer - Especially Triple Negative Breast Cancer},
  journal = {Oncomedicine},
  year = {2017},
  doi = {10.7150/oncm.21071}
}
Kostenlos starten →